Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2699

1.

Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.

Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.

J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.

PMID:
18436152
2.

Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis.

Yoon W, Park MS, Cho KH.

AJNR Am J Neuroradiol. 2010 Jan;31(1):161-4. doi: 10.3174/ajnr.A1746. Epub 2009 Aug 27.

3.

Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.

Bourekas EC, Slivka AP, Shah R, Sunshine J, Suarez JI.

Neurosurgery. 2004 Jan;54(1):39-44; discussion 44-6.

PMID:
14683539
4.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
5.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

6.

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.

Arch Neurol. 2008 May;65(5):607-11. doi: 10.1001/archneur.65.5.noc70077. Epub 2008 Mar 10.

PMID:
18332238
7.

Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.

Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.

J Stroke Cerebrovasc Dis. 2008 Sep;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.

PMID:
18755405
8.

Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset.

Sugiura S, Iwaisako K, Toyota S, Takimoto H.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1061-6. doi: 10.3174/ajnr.A1012. Epub 2008 Mar 27.

9.

Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.

Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, Selman WR, Landis DM.

Stroke. 2002 Jul;33(7):1821-6.

10.

Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.

Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.

Cerebrovasc Dis. 2008;25(1-2):129-35. Epub 2007 Dec 11.

PMID:
18073466
11.

Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.

Sharma VK, Tsivgoulis G, Tan JH, Wong LY, Ong BK, Chan BP, Teoh HL.

J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):424-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.015.

PMID:
20554224
12.

Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke.

Zhou XY, Wang SS, Collins ML, Davis SM, Yan B.

J Clin Neurosci. 2010 Aug;17(8):988-92. doi: 10.1016/j.jocn.2009.12.005. Epub 2010 May 26.

PMID:
20510615
14.

Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.

Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):124-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.010. Epub 2010 Jul 3.

PMID:
20598579
15.

Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?

Hermann A, Dzialowski I, Koch R, Gahn G.

J Neurol Sci. 2009 Sep 15;284(1-2):155-7. doi: 10.1016/j.jns.2009.05.003. Epub 2009 May 26.

PMID:
19473668
16.

Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.

Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.

Cerebrovasc Dis. 2010 Feb;29(3):263-7. doi: 10.1159/000275500. Epub 2010 Jan 15.

PMID:
20090317
17.

Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.

Sekoranja L, Loulidi J, Yilmaz H, Lovblad K, Temperli P, Comelli M, Sztajzel RF.

Stroke. 2006 Jul;37(7):1805-9. Epub 2006 Jun 8.

18.

Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 May;22(4):545-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.022. Epub 2013 Feb 28.

PMID:
23453555
19.

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.

Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T.

Stroke. 1999 Dec;30(12):2598-605.

20.

Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.

Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.

Isr Med Assoc J. 2004 Feb;6(2):70-4.

Supplemental Content

Support Center